SMTL ID : 5icy.1 (1 other biounit)

Cetuximab Fab in complex with linear meditope

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.50 Å

Oligo State

hetero-1-1-1-mer

Ligands

4 x PO4: PHOSPHATE ION(Non-functional Binders)

PO4.1: 5 residues within 4Å: Chain A: T.164, E.165, D.167 Chain B: V.169, H.170 7 PLIP interactions: 5 interactions with chain A, 2 interactions with chain B Hydrogen bonds: A:D.167 Water bridges: A:T.164, A:E.165, A:E.165, A:S.174, B:T.171 Salt bridges: B:H.170 PO4.2: 6 residues within 4Å: Chain A: F.98, G.99, A.100 Chain B: K.43, G.44, L.45 4 PLIP interactions: 2 interactions with chain B, 2 interactions with chain A Hydrogen bonds: B:L.45, A:G.99 Water bridges: B:G.42, A:F.98 PO4.3: 2 residues within 4Å: Chain B: S.126, V.127 4 PLIP interactions: 4 interactions with chain B Hydrogen bonds: B:P.125, B:V.127 Water bridges: B:V.127, B:K.215 PO4.4: 4 residues within 4Å: Chain B: N.205, K.207, N.210, K.212 3 PLIP interactions: 3 interactions with chain B Hydrogen bonds: B:N.205, B:K.207, B:N.210

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Bzymek, K.P. et al., Cyclization strategies of meditopes: affinity and diffraction studies of meditope-Fab complexes. Acta Crystallogr F Struct Biol Commun (2016)

Release Date

2016-06-15

Peptides

Cetuximab Fab light chain: A
Cetuximab Fab heavy chain: B
Meditope: C

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
E

Cetuximab Fab light chain

Cetuximab Fab heavy chain

Meditope

Related Entries With Identical Sequence